As co-chairs of the Barrier Track program at the 2018 ISPE Aseptic Conference, Michael Faia and I built this year’s program around real-world case studies from an all-star line-up of leading sterile manufacturers including:
Bristol Meyers Squibb
Glaxo Smith Kline
This optimized case study format tells eight stories of major, real-world sterile projects by actual owners. These narrative-style presentations explain project goals, time lines, problems and challenges, and how issues were overcome. We have maximized the engineering focus in 2018, covering technical issues, problem solving, risk analysis, and lessons learned using numerous pictures, layouts, diagrams, and data.
Combo/Flex fillers and RTU components, make-vs-buy
Robotic advancements … are gloveless isolators catching on?
Legacy facility modernization including 2017 industry poll results
Hybrid RABS/Isolators with H2O2 room decontamination
Disposables and Technical Transfer
Multi product-family facilities to maximize capital assets
Update on Annex 1 and Grade A supply/local protection
The 2018 ISPE Aseptic Conference, 6 -7 March in Reston, VA, marks 27 years of providing critical information about engineering solutions and how to provide cost effective facilities which make best use of available modern technology to ensure that products of the highest quality are consistently and reliably manufactured. The conference educates pharmaceutical manufacturing professionals, especially engineers.
In two packed days, you will get a panoramic view of what is trending around the world and how leading companies in sterile manufacturing are bringing innovation and advanced aseptic technology on-line. The 2018 ISPE Aseptic Conference will have a topic of interest for everyone!
I invite you as fellow engineers to check-out this optimized case-study format for the Barrier Track at 2018 ISPE Aseptic Conference. Stay tuned over the next several weeks, as we continue to share more reasons on why the 2018 ISPE Aseptic Conference is the must-attend conference for aseptic processing. We look forward to seeing you there.
One of the most significant changes to the pharmaceutical industry in the last decade has been the increased speed in developing new therapies. A striking example of this is the rapid rollout of the COVID-19 vaccines. What usually took 10-15 years was researched, developed, and put into production...
Biocon Biologics is one of the 2021 Facility of the Year Awards Winner for the 2021 Facility of the Year Honorable Mention Award for their Biocon Biologics Manufacturing (B3) project in Bangalore, India.
ICH Q10 outlines three objectives: achieve product realization, establish and maintain a state of control, and facilitate continual improvement. Embracing these objectives can be best achieved using the dual enablers, Knowledge Management (KM) and Quality Risk Management (QRM). The pharmaceutical...